Glucose Metabolism Disorders  >>  BMS-820132  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BMS-820132 / BMS
NCT01105429: Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Completed
1
56
US
BMS-820132, Placebo
Bristol-Myers Squibb
Diabetes Mellitus, Non-Insulin-Dependent
10/10
10/10
NCT01290575: Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Completed
1
67
US
Placebo, BMS-820132
Bristol-Myers Squibb
Type 2 Diabetes
11/11
11/11

Download Options